- Home
- SAGE vs SKYT Comparison
SAGE vs SKYT Comparison
Compare SAGE & SKYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAGE
- SKYT
- Stock Information
- Founded
- SAGE 2010
- SKYT 1991
- Country
- SAGE United States
- SKYT United States
- Employees
- SAGE N/A
- SKYT N/A
- Industry
- SAGE Biotechnology: Pharmaceutical Preparations
- SKYT Semiconductors
- Sector
- SAGE Health Care
- SKYT Technology
- Exchange
- SAGE Nasdaq
- SKYT Nasdaq
- Market Cap
- SAGE 462.2M
- SKYT 426.4M
- IPO Year
- SAGE 2014
- SKYT 2021
- Fundamental
- Price
- SAGE $5.01
- SKYT $8.37
- Analyst Decision
- SAGE Hold
- SKYT Strong Buy
- Analyst Count
- SAGE 20
- SKYT 4
- Target Price
- SAGE $12.89
- SKYT $12.75
- AVG Volume (30 Days)
- SAGE 854.9K
- SKYT 419.6K
- Earning Date
- SAGE 10-29-2024
- SKYT 11-07-2024
- Dividend Yield
- SAGE N/A
- SKYT N/A
- EPS Growth
- SAGE N/A
- SKYT N/A
- EPS
- SAGE N/A
- SKYT N/A
- Revenue
- SAGE $106,399,000.00
- SKYT $345,935,000.00
- Revenue This Year
- SAGE N/A
- SKYT $22.45
- Revenue Next Year
- SAGE $118.26
- SKYT N/A
- P/E Ratio
- SAGE N/A
- SKYT N/A
- Revenue Growth
- SAGE 837.60
- SKYT 26.89
- 52 Week Low
- SAGE $4.62
- SKYT $5.63
- 52 Week High
- SAGE $28.26
- SKYT $12.97
- Technical
- Relative Strength Index (RSI)
- SAGE 32.20
- SKYT 42.32
- Support Level
- SAGE $4.62
- SKYT $7.81
- Resistance Level
- SAGE $5.87
- SKYT $8.98
- Average True Range (ATR)
- SAGE 0.39
- SKYT 0.58
- MACD
- SAGE -0.10
- SKYT -0.13
- Stochastic Oscillator
- SAGE 21.18
- SKYT 18.68
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.
About SKYT SkyWater Technology Inc.
SkyWater Technology Inc is a U.S.-based, independent, pure-play technology foundry that offers semiconductor development and manufacturing services from its fabrication facilities. In its technology as a service model, it leverages a foundation of proprietary technology, engineering to co-develop process technology intellectual property (IP) with its customers that enable disruptive concepts through its Technology Services for diverse microelectronics (integrated circuits) and related micro- and nanotechnology applications. It focuses on serving diversified, high-growth, end users in numerous vertical markets, including computation, aerospace and defense (A&D), automotive and transportation, bio-health, and industrial.